Research article
Height is an independent risk factor for neuropathy in diabetic men

https://doi.org/10.1016/0168-8227(92)90079-7Get rights and content

Abstract

Height may increase the risk of diabetic polyneuropathy, but previous studies are inconclusive. Our purposes were to further examine the hypothesis that height (HT) is an independent risk factor for diabetic polyneuropathy and to determine which electrophysiologic measures are influenced by HT in diabetic subjects. We studied 170 Japanese American men (ages 43–73 years, mean 61) including: 69 diabetic men (mean HT 166 cm), 54 normal men (mean HT 167 cm), and 47 men with impaired glucose tolerance (IGT) (mean HT 164 cm), measuring 28 nerve conduction study (NCS) parameters. We used data from normal men in developing regression models to adjust NCS parameters for HT, age, and temperature. Factor analysis was employed to reduce the 28 NCS parameters to five physiologically meaningful factors, one of which, a factor representing median and peroneal sensory amplitudes, was significantly correlated with HT (r = −0.38, P = 0.0011) in diabetic men; taller subjects having smaller sensory nerve amplitudes. No significant correlation was found between this factor and body mass index. This factor had no correlation with HT in normal or IGT men. Our data do not confirm previous reports of associations between HT and slowed motor conduction velocities in diabetic subjects. This study does, however, support the hypothesis that HT is an independent risk factor for sensory polyneuropathy in diabetic subjects.

References (12)

There are more references available in the full text version of this article.

Cited by (27)

  • Electromyography in Pediatrics

    2015, Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach
  • Painful diabetic neuropathy: Diagnosis and management

    2011, Diabetes and Metabolism
    Citation Excerpt :

    Harris et al. [6] showed that arterial hypertension was significantly associated with PDN. Tall stature has been implicated as a risk factor for neuropathy because of the length-dependent deterioration of nerve fibres [27,28]; however, unlike sensitivity loss, the patient's height was not a significant, independent factor for the occurrence of pain [25]. The role of hyperglycaemia is not clear as regards the painful component of CSDPN [5,6,10,25].

  • Management of painful diabetic polyneuropathy

    2011, Medecine des Maladies Metaboliques
  • Neuropathic Problems of the Lower Limbs in Diabetic Patients

    2008, Levin and O'Neal's: The Diabetic Foot
  • Neuropathic Problems of the Lower Limbs in Diabetic Patients

    2007, Levin and O'Neal's The Diabetic Foot with CD-ROM
View all citing articles on Scopus

This paper was presented as an abstract and poster at the meeting on Epidemiology of Diabetes and Its Complications, 14th International Diabetes Federation Congress Satellite, Williamsburg, VA, 1991.

View full text